623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1818724289671593984 |
|---|---|
| author | Ronald Seidel Mohammad Rashidian Stad Zeigler Andrew Woodham Mengyan Li Ella Zeyang Stephen Kolifrath Kaitlyn O’Connor Rodolfo Chaparro Maia Mesyngier Ross Cheloha Jason Dearling Phaneendra Duddempudi Alev Celikgil Scott Garforth Alan Packard Harris Goldstein Hidde Ploegh Steven Almo |
| author_facet | Ronald Seidel Mohammad Rashidian Stad Zeigler Andrew Woodham Mengyan Li Ella Zeyang Stephen Kolifrath Kaitlyn O’Connor Rodolfo Chaparro Maia Mesyngier Ross Cheloha Jason Dearling Phaneendra Duddempudi Alev Celikgil Scott Garforth Alan Packard Harris Goldstein Hidde Ploegh Steven Almo |
| author_sort | Ronald Seidel |
| collection | DOAJ |
| first_indexed | 2024-12-17T21:24:03Z |
| format | Article |
| id | doaj.art-c911b330d5f445948d01a28f9e0ba4c0 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-17T21:24:03Z |
| publishDate | 2020-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-c911b330d5f445948d01a28f9e0ba4c02022-12-21T21:32:05ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0623623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivoRonald Seidel0Mohammad Rashidian1Stad Zeigler2Andrew Woodham3Mengyan Li4Ella Zeyang5Stephen Kolifrath6Kaitlyn O’Connor7Rodolfo Chaparro8Maia Mesyngier9Ross Cheloha10Jason Dearling11Phaneendra Duddempudi12Alev Celikgil13Scott Garforth14Alan Packard15Harris Goldstein16Hidde Ploegh17Steven Almo5Cue Biopharma, Cambridge, MA, USA2Dana Farber Cancer Institute, Boston, MA, USA1Albert Einstein College of Medicine, Bronx, NY, USA2Boston Children’s Hospital, Boston, MA, USA1Albert Einstein College of Medicine, Bronx, NY, USA3Massachusetts Institute of Technology, Cambridge, MA, USA2Boston Children’s Hospital, Boston, MA, USA1Albert Einstein College of Medicine, Bronx, NY, USA5Cue Biopharma, Cambridge, MA, USA2Boston Children’s Hospital, Boston, MA, USA2Boston Children’s Hospital, Boston, MA, USA2Boston Children’s Hospital, Boston, MA, USA1Albert Einstein College of Medicine, Bronx, NY, USA1Albert Einstein College of Medicine, Bronx, NY, USA1Albert Einstein College of Medicine, Bronx, NY, USA2Boston Children’s Hospital, Boston, MA, USA1Albert Einstein College of Medicine, Bronx, NY, USA2Boston Children’s Hospital, Boston, MA, USA |
| spellingShingle | Ronald Seidel Mohammad Rashidian Stad Zeigler Andrew Woodham Mengyan Li Ella Zeyang Stephen Kolifrath Kaitlyn O’Connor Rodolfo Chaparro Maia Mesyngier Ross Cheloha Jason Dearling Phaneendra Duddempudi Alev Celikgil Scott Garforth Alan Packard Harris Goldstein Hidde Ploegh Steven Almo 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo Journal for ImmunoTherapy of Cancer |
| title | 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo |
| title_full | 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo |
| title_fullStr | 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo |
| title_full_unstemmed | 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo |
| title_short | 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo |
| title_sort | 623 immuno stats leveraging protein engineering to expand and track antigen specific t cells in vivo |
| work_keys_str_mv | AT ronaldseidel 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT mohammadrashidian 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT stadzeigler 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT andrewwoodham 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT mengyanli 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT ellazeyang 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT stephenkolifrath 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT kaitlynoconnor 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT rodolfochaparro 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT maiamesyngier 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT rosscheloha 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT jasondearling 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT phaneendraduddempudi 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT alevcelikgil 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT scottgarforth 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT alanpackard 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT harrisgoldstein 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT hiddeploegh 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo AT stevenalmo 623immunostatsleveragingproteinengineeringtoexpandandtrackantigenspecifictcellsinvivo |